QardioArm Blood Pressure Monitoring in a Population With Type 2 Diabetes: Validation Study

Use this link to cite
http://hdl.handle.net/2183/26195Collections
- Investigación (FEP) [494]
Metadata
Show full item recordTitle
QardioArm Blood Pressure Monitoring in a Population With Type 2 Diabetes: Validation StudyAuthor(s)
Date
2020-07Citation
Mazoteras-Pardo V, Becerro-De-Bengoa-Vallejo R, Losa-Iglesias ME, Martínez-Jiménez EM, Calvo-Lobo C, Romero-Morales C, López-López D, Palomo-López P QardioArm Blood Pressure Monitoring in a Population With Type 2 Diabetes: Validation Study J Med Internet Res 2020;22(7):e19781 DOI: 10.2196/19781
Abstract
[Abstract] Background: Home blood pressure monitoring has many benefits, even more so, in populations prone to high blood pressure, such as persons with diabetes.
Objective: The purpose of this research was to validate the QardioArm mobile device in a sample of individuals with noninsulin-dependent type 2 diabetes in accordance with the guidelines of the second International Protocol of the European Society of Hypertension.
Methods: The sample consisted of 33 patients with type 2 diabetes. To evaluate the validity of QardioArm by comparing its data with that obtained with a digital sphygmomanometer (Omron M3 Intellisense), two nurses collected diastolic blood pressure, systolic blood pressure, and heart rate with both devices.
Results: The analysis indicated that the test device QardioArm met all the validation requirements using a sample population with type 2 diabetes.
Conclusions: This paper reports the first validation of QardioArm in a population of individuals with noninsulin-dependent type 2 diabetes. QardioArm for home monitoring of blood pressure and heart rate met the requirements of the second International Protocol of the European Society of Hypertension.
Keywords
Blood pressure
Hypertension
Type 2 diabetes
Mobile applications
Software validation
Hypertension
Type 2 diabetes
Mobile applications
Software validation
Editor version
Rights
Atribución 4.0 Internacional
ISSN
1438-8871